Vimal Mehta
2018
In 2018, Vimal Mehta earned a total compensation of $701.6K as President and Chief Executive Officer at BioXcel Therapeutics, a 147% increase compared to previous year.
Compensation breakdown
| Bonus | $270,000 |
|---|---|
| Salary | $423,359 |
| Other | $8,250 |
| Total | $701,609 |
Mehta received $423.4K in salary, accounting for 60% of the total pay in 2018.
Mehta also received $270K in bonus and $8.3K in other compensation.
Rankings
In 2018, Vimal Mehta's compensation ranked 10,699th out of 14,244 executives tracked by ExecPay. In other words, Mehta earned more than 24.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,699 out of 14,244 | 25th |
Division Manufacturing | 4,313 out of 5,765 | 25th |
Major group Chemicals And Allied Products | 1,630 out of 2,128 | 23rd |
Industry group Drugs | 1,379 out of 1,817 | 24th |
Industry Pharmaceutical Preparations | 1,058 out of 1,391 | 24th |
Source: SEC filing on April 1, 2019.
Mehta's colleagues
We found two more compensation records of executives who worked with Vimal Mehta at BioXcel Therapeutics in 2018.
News
BioXcel Therapeutics CEO Vimal Mehta's 2023 pay rises 4% to $4.7M
April 29, 2024
BioXcel Therapeutics CEO Vimal Mehta's 2022 pay falls 51% to $4.6M
May 17, 2023
BioXcel Therapeutics CEO Vimal Mehta's 2021 pay slips 2% to $9.4M
April 5, 2022
BioXcel Therapeutics CEO Vimal Mehta's 2020 pay jumps 386% to $9.6M
April 27, 2021
BioXcel Therapeutics CEO Vimal Mehta's 2019 pay jumps 181% to $2M
April 6, 2020
BioXcel Therapeutics CEO Vimal Mehta's 2018 pay jumps 147% to $702K
April 1, 2019